Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Mullier

Showing results (1-10 of 180) with videos related to

Pageof 18
Sort By:
Thrombosis Research|August 26, 2023
Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectivelyMarion Bareille, Thomas Lecompte, François Mullier
Polish Archives of Internal Medicine|March 19, 2026
Hemostasis assessment in patients suspected of venous thrombosis and pulmonary embolism in the emergency setting: challenges for cliniciansGiuseppe Lippi, François Mullier, Emmanuel J Favaloro
Expert Opinion on Drug Safety|May 22, 2015
Dose tailoring of dabigatran etexilate: obvious or excessive?Jonathan Douxfils, François Mullier, Jean-Michel Dogné
Molecules (Basel, Switzerland)|April 12, 2017
Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A ReviewValentine Minet, Jean-Michel Dogné, François Mullier
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
"Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis": comment from Gouin-Thibault et alIsabelle Gouin-Thibault, François Mullier, Thomas Lecompte
Clinical Chemistry and Laboratory Medicine|July 18, 2022
D-dimer: old dogmas, new (COVID-19) tricksGiuseppe Lippi, François Mullier, Emmanuel J Favaloro
Journal of Thrombosis and Haemostasis : JTH|June 21, 2025
Attempts to align research in thrombosis and hemostasis with the In Vitro Diagnostic Medical Device Regulation (IVDR, European Union) requirementsFrançois Mullier, Piet Meijer, Christa Cobbaert, et al.
Thrombosis Research|November 3, 2019
Concomitant assessment of rivaroxaban concentration and its impact on thrombin generationSaartje Bloemen, Suzanne Zwaveling, François Mullier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 22, 2016
Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case reportGeoffrey Horlait, Valentine Minet, François Mullier, et al.
Annales De Biologie Clinique|May 26, 2017
From XE-2100 to XN-9000, from SIS Standard to GFHC recommendations for slide review: potential impact on review rate and turnaround timeAnne Tamigniau, Nicolas Bailly, Bernard Chatelain, et al.
Pageof 18

Showing results (1-10 of 180) with videos related to

Sort By:
Pageof 18
Thrombosis Research|August 26, 2023
Assessment of the individual determinants of two fibrinolysis assays, GFC and ECLT in platelet-depleted plasma and derived euglobulin fraction respectivelyMarion Bareille, Thomas Lecompte, François Mullier
Polish Archives of Internal Medicine|March 19, 2026
Hemostasis assessment in patients suspected of venous thrombosis and pulmonary embolism in the emergency setting: challenges for cliniciansGiuseppe Lippi, François Mullier, Emmanuel J Favaloro
Expert Opinion on Drug Safety|May 22, 2015
Dose tailoring of dabigatran etexilate: obvious or excessive?Jonathan Douxfils, François Mullier, Jean-Michel Dogné
Molecules (Basel, Switzerland)|April 12, 2017
Functional Assays in the Diagnosis of Heparin-Induced Thrombocytopenia: A ReviewValentine Minet, Jean-Michel Dogné, François Mullier
Journal of Thrombosis and Haemostasis : JTH|February 3, 2024
"Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis": comment from Gouin-Thibault et alIsabelle Gouin-Thibault, François Mullier, Thomas Lecompte
Clinical Chemistry and Laboratory Medicine|July 18, 2022
D-dimer: old dogmas, new (COVID-19) tricksGiuseppe Lippi, François Mullier, Emmanuel J Favaloro
Journal of Thrombosis and Haemostasis : JTH|June 21, 2025
Attempts to align research in thrombosis and hemostasis with the In Vitro Diagnostic Medical Device Regulation (IVDR, European Union) requirementsFrançois Mullier, Piet Meijer, Christa Cobbaert, et al.
Thrombosis Research|November 3, 2019
Concomitant assessment of rivaroxaban concentration and its impact on thrombin generationSaartje Bloemen, Suzanne Zwaveling, François Mullier, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 22, 2016
Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case reportGeoffrey Horlait, Valentine Minet, François Mullier, et al.
Annales De Biologie Clinique|May 26, 2017
From XE-2100 to XN-9000, from SIS Standard to GFHC recommendations for slide review: potential impact on review rate and turnaround timeAnne Tamigniau, Nicolas Bailly, Bernard Chatelain, et al.
Pageof 18